New drug combination therapy developed to treat leukemia
A new, pre-clinical study by researchers at Virginia Commonwealth University Massey Cancer Center suggests that a novel drug combination could lead to profound leukemia cell death by disrupting the function of two major pro-survival ...
Cancer
Apr 17, 2013 |
5 / 5 (1) |
0
Researchers study use of dasatinib for patients with high-risk MDS
Researchers at Moffitt Cancer Center have completed a phase II clinical trial to determine the safety and efficacy of dasatinib for patients with higher-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia, ...
Cancer
Mar 21, 2013 |
not rated yet |
0
Stem cell survival strategy key to blood and immune system health
Stem cells of the aging bone marrow recycle their own molecules to survive and keep replenishing the blood and immune systems as the body ages, researchers at UC San Francisco (UCSF) have discovered.
Medical research
Feb 14, 2013 |
5 / 5 (3) |
0
|
Weekly dose reduces targeted drug's side effects, but not its activity against ALL
A potent chemotherapy agent wrapped within a monoclonal antibody selectively destroys the malignant cells responsible for acute lymphocytic leukemia (ALL) in either weekly or monthly dosing, researchers report at the 54th ...
Cancer
Dec 11, 2012 |
not rated yet |
0
Researchers find novel predictor for MDS progression risk
Researchers at Moffitt Cancer Center and colleagues have discovered that changes in the physical characteristics of the effector memory regulatory T cell can predict the progression risk of myelodysplastic syndromes (MDS) ...
Immunology
Sep 13, 2012 |
not rated yet |
0
|
Researchers prove that leukemias arise from changes that accumulate in blood stem cells
(Medical Xpress)—Imagine that a police bomb squad comes upon a diabolically designed bomb controlled by a tangled mass of different wires, lights and switches, some of which have a real function while others are decoys. ...
Cancer
Aug 30, 2012 |
3.8 / 5 (4) |
1
|
Researchers uncover new clues to the development of blood and other cancers
Scientists at Fox Chase Cancer Center have uncovered more details about how defects in components of the machinery that makes new proteins can lead to blood and other cancers. The findings, which will be presented at the ...
Cancer
Apr 02, 2012 |
5 / 5 (1) |
0
Genetic profiling helps doctors more accurately predict prognosis, guide treatment decisions for leukemia patients
Researchers have identified a set of genetic abnormalities in patients with acute myelogenous leukemia (AML) that doctors can use to more accurately predict patients' prognoses and select treatments that are most likely to ...
Cancer
Mar 14, 2012 |
5 / 5 (1) |
0
|
20 cancer cases in French women with PIP implants: agency
French health authorities said Friday that 20 cases of cancer had been uncovered in women with allegedly faulty French-made breast implants but insisted there was still no proven link with the disease.
Cancer
Dec 30, 2011 |
2 / 5 (1) |
0
Tough choice looms on 9/11 health lawsuits
(AP) -- More than 1,600 people who filed lawsuits claiming that their health was ruined by dust and smoke from the collapsed World Trade Center must decide by Jan. 2 whether to keep fighting in court, or ...
Health
Dec 26, 2011 |
5 / 5 (1) |
2
Bedside assessment may provide better outcomes for older cancer patients
In geriatric medicine, the adage that age is just a number holds true. New research from Wake Forest Baptist Medical Center uses a simple assessment tool to determine how well older adults diagnosed with acute myelogenous ...
Cancer
Oct 26, 2011 |
5 / 5 (1) |
0
Cardiovascular drug may offer new treatment for some difficult types of leukemia
A drug now prescribed for cardiovascular problems could become a new tool in physicians' arsenals to attack certain types of leukemia that so far have evaded effective treatments, researchers say.
Cancer
Sep 12, 2011 |
not rated yet |
0
|
Scientists reveal mechanism behind 'oncogene addiction' in acute leukemia
A team of scientists at Cold Spring Harbor Laboratory (CSHL) has laid bare the mechanism behind a phenomenon called oncogene addiction in mice suffering from a form of leukemia that mimics acute myelogenous leukemia (AML) ...
Addiction
Aug 01, 2011 |
5 / 5 (1) |
0
|
New drug stops aggressive form of childhood leukemia
In a significant breakthrough, investigators at Weill Cornell Medical College and the University of California, San Francisco, have been able to overcome resistance of a form of leukemia to targeted therapy, demonstrating ...
Cancer
May 24, 2011 |
5 / 5 (3) |
0
|
